Barclays’s Medline Inc MDLN Stock Holding History

Barclays’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.15M	Buy	+33,000	New	+$1.21M	﹤0.01%	2953

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Egerton Capital (UK) London, United Kingdom $9.8B AUM 22.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Barclays's MDLN Position: Q3 2026 in Review

Barclays increased its Medline Inc (MDLN) stake by 260% in Q3 2026, buying an estimated $24.2M and bringing the position to 917,828 shares worth $31.8M. The position accounts for 0.01% of the portfolio, ranked #994.

Barclays first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. 293 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

Barclays held 917,828 shares of Medline Inc worth $31.8M as of Q3 2026.
Barclays bought 662,809 Medline Inc shares in Q3 2026, an estimated $24.2M.
Medline Inc made up 0.01% of Barclays's portfolio in Q3 2026, its #994 holding.
Barclays first reported a position in Medline Inc in Q1 2026 and has held it in 3 quarters since.
293 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.